Next Generation Gravitational Wave Observatories Could Detect 100-600 Solar Mass Black Hole Mergers
FDA approves the first treatment for nasopharyngeal carcinoma, a rare cancer that originates in the nasopharynx. The drug (toripalimab-tpzi) is a next-generation, programmed death receptor-1 monoclonal antibody. Because of the tumor's location (behind the nose), surgery is not usually an option.
Scientists build on artificial intelligence to create next-generation gastric acid treatment